InvestorsHub Logo
Followers 43
Posts 2466
Boards Moderated 0
Alias Born 04/08/2010

Re: None

Wednesday, 02/15/2023 9:11:46 AM

Wednesday, February 15, 2023 9:11:46 AM

Post# of 43803



They had 10 years to prepare for filing the BLA and didn’t plan

“Due to the unprecedented size, scope, length of study and nature of our Phase 3 study and the fact that Multikine is intended as a first-line treatment for primary, advanced head and neck cancer, the BLA submission has required tremendous time and effort, including expansion of the team to include independent medical and regulatory experts”

I’m calling out the bs

Woof
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News